Cumberland Pharmaceuticals Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Cumberland Pharmaceuticals Inc. (CPIX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 666.91 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 688.91K shares, a 14.97% decline year-over-year.
- Cumberland Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 810.21K shares, a 63.07% increase year-over-year.
- Cumberland Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 496.86K shares, a 49.96% increase year-over-year.
- Cumberland Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 331.34K shares, a 152.50% increase year-over-year.
- Cumberland Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 891.38K shares, a 45.80% increase from fiscal 2024.
- Cumberland Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 611.35K shares, a 35.19% increase from fiscal 2023.
- Cumberland Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 452.22K shares, a 99.17% increase from fiscal 2022.
- Cumberland Pharmaceuticals Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 227.05K shares, a 23.87% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 666.91K shares 10-Q · filed 2026-08-07 | |||||
| 2026-03-31 | 688.91K shares 10-Q · filed 2026-05-08 | |||||
| 2025-12-31 | 891.38K shares 10-K · filed 2026-03-09 | |||||
| 2025-09-30 | 737.97K shares 10-Q · filed 2025-11-07 | |||||
| 2025-06-30 | 753.09K shares 10-Q · filed 2026-08-07 | |||||
| 2025-03-31 | 810.21K shares 10-Q · filed 2026-05-08 | |||||
| 2024-12-31 | 611.35K shares 10-K · filed 2026-03-09 | |||||
| 2024-09-30 | 600.27K shares 10-Q · filed 2025-11-07 | |||||
| 2024-06-30 | 576.52K shares 10-Q · filed 2025-08-08 | |||||
| 2024-03-31 | 496.86K shares 10-Q · filed 2025-05-09 | |||||
| 2023-12-31 | 452.22K shares 10-K · filed 2025-03-07 | |||||
| 2023-09-30 | 440.39K shares 10-Q · filed 2024-11-08 | |||||
| 2023-06-30 | 413.07K shares 10-Q · filed 2024-08-09 | |||||
| 2023-03-31 | 331.34K shares 10-Q · filed 2024-05-10 | |||||
| 2022-12-31 | 227.05K shares 10-K · filed 2024-03-13 | |||||
| 2022-09-30 | 233.75K shares 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | 289.98K shares 10-Q · filed 2023-08-11 | |||||
| 2022-03-31 | 131.22K shares 10-Q · filed 2023-05-12 | |||||
| 2021-12-31 | 183.30K shares 10-K · filed 2023-03-13 | |||||
| 2021-09-30 | 158.90K shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 198.30K shares 10-Q · filed 2022-08-12 | |||||
| 2021-03-31 | 215.60K shares 10-Q · filed 2022-05-13 | |||||
| 2020-12-31 | 197.61K shares 10-K · filed 2022-03-11 | |||||
| 2020-09-30 | 197.21K shares 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | 13.50K shares 10-Q · filed 2021-08-13 | 199.21K shares 10-Q · filed 2020-08-14 | ||||
| 2020-03-31 | 431.23K shares 10-Q · filed 2021-05-14 | |||||
| 2019-12-31 | 4.00K shares 10-K · filed 2022-03-11 | |||||
| 2019-09-30 | 3.60K shares 10-Q · filed 2020-11-13 | |||||
| 2019-06-30 | 13.50K shares 10-Q · filed 2020-08-14 | |||||
| 2019-03-31 | 263.92K shares 10-Q · filed 2020-05-22 | |||||
| 2018-12-31 | 41.65K shares 10-K · filed 2021-03-12 | |||||
| 2018-09-30 | 18.32K shares 10-Q · filed 2019-11-13 | |||||
| 2018-06-30 | 231.91K shares 10-Q · filed 2019-08-14 | |||||
| 2018-03-31 | 247.53K shares 10-Q · filed 2019-05-15 | |||||
| 2017-12-31 | 18.32K shares 8-K · filed 2020-12-10 | |||||
| 2017-09-30 | 14.18K shares 10-Q · filed 2018-11-14 | |||||
| 2017-06-30 | 20.38K shares 10-Q · filed 2018-08-14 | |||||
| 2017-03-31 | 237.88K shares 10-Q · filed 2018-05-09 | |||||
| 2016-12-31 | 13.30K shares 10-K · filed 2019-03-12 | |||||
| 2016-09-30 | 21.95K shares 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | 23.76K shares 10-Q · filed 2017-08-09 | 276.65K shares 10-Q · filed 2016-08-05 | ||||
| 2016-03-31 | 257.31K shares 10-Q · filed 2017-05-15 | |||||
| 2015-12-31 | 46.63K shares 10-K · filed 2018-03-09 | |||||
| 2015-09-30 | 54.80K shares 10-Q · filed 2016-11-03 | |||||
| 2015-06-30 | 53.97K shares 10-Q · filed 2016-08-05 | |||||
| 2015-03-31 | 256.59K shares 10-Q · filed 2016-05-13 | |||||
| 2014-12-31 | 194.24K shares 10-K · filed 2017-03-13 | |||||
| 2014-09-30 | 187.25K shares 10-Q · filed 2015-11-06 | |||||
| 2014-06-30 | 188.81K shares 10-Q · filed 2015-08-07 | |||||
| 2014-03-31 | 582.58K shares 10-Q · filed 2015-05-15 | |||||
| 2013-12-31 | 407.95K shares 10-K · filed 2016-03-14 | |||||
| 2013-09-30 | 554.28K shares 10-Q · filed 2014-11-07 | 554.03K shares 10-Q · filed 2013-11-06 | ||||
| 2013-06-30 | 554.28K shares 10-Q · filed 2014-08-08 | |||||
| 2013-03-31 | 878.48K shares 10-Q · filed 2014-05-12 | |||||
| 2012-12-31 | 687.43K shares 10-K · filed 2015-03-09 | |||||
| 2012-09-30 | 271.26K shares 10-Q · filed 2013-11-06 | 250.28K shares 10-Q · filed 2012-11-02 | ||||
| 2012-06-30 | 271.26K shares 10-Q · filed 2013-08-09 | |||||
| 2012-03-31 | 666.73K shares 10-Q · filed 2013-05-08 | |||||
| 2011-12-31 | 1.08M shares 10-K · filed 2014-03-11 | |||||
| 2011-09-30 | 1.08M shares 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | 1.15M shares 10-Q · filed 2012-08-09 | |||||
| 2010-12-31 | 640.72K shares 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |